Anhui Huaheng Biotechnology Co. Ltd. A Asset Resilience Ratio

Latest as of September 2023: 0.71%

Anhui Huaheng Biotechnology Co. Ltd. A asset resilience ratio. Anhui Huaheng Biotechnology Co. Ltd. A (688639) has an Asset Resilience Ratio of 0.71% as of September 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Anhui Huaheng Biotechnology Co. Ltd. A (688639) defensive interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥20.00 Million

≈ $2.93 Million USD Cash + Short-term Investments

Total Assets

CN¥2.81 Billion

≈ $411.12 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Anhui Huaheng Biotechnology Co. Ltd. A (2021–2022)

Asset resilience ratio of Anhui Huaheng Biotechnology Co. Ltd. A from 2021 to 2022. This chart shows how Anhui Huaheng Biotechnology Co. Ltd. A's Asset Resilience Ratio has changed over time. Read total liabilities of Anhui Huaheng Biotechnology Co. Ltd. A for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Anhui Huaheng Biotechnology Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Anhui Huaheng Biotechnology Co. Ltd. A balance sheet assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥20.00 Million	0.71%
Total Liquid Assets	CN¥20.00 Million	0.71%

Asset Resilience Insights

Limited Liquidity: Anhui Huaheng Biotechnology Co. Ltd. A maintains only 0.71% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Anhui Huaheng Biotechnology Co. Ltd. A Industry Peers by Asset Resilience Ratio

Compare Anhui Huaheng Biotechnology Co. Ltd. A's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
argenx NV ADR NASDAQ:ARGX	Biotechnology	15.95%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
Summit Therapeutics PLC NASDAQ:SMMT	Biotechnology	36.07%
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	Biotechnology	62.31%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Verona Pharma PLC ADR NASDAQ:VRNA	Biotechnology	0.00%
3SBio Inc F:83B	Biotechnology	10.64%

Anhui Huaheng Biotechnology Co. Ltd. A Asset Resilience Ratio by Year (2021–2022)

Anhui Huaheng Biotechnology Co. Ltd. A asset resilience ratio by year from 2021 to 2022. The table below shows the annual Asset Resilience Ratio data for Anhui Huaheng Biotechnology Co. Ltd. A.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2022-12-31	9.88%	CN¥200.31 Million ≈ $29.31 Million	CN¥2.03 Billion ≈ $296.63 Million	-13.26pp
2021-12-31	23.14%	CN¥341.06 Million ≈ $49.91 Million	CN¥1.47 Billion ≈ $215.71 Million	--

pp = percentage points

About Anhui Huaheng Biotechnology Co. Ltd. A

SHG:688639 China Biotechnology

Market Cap

$618.54 Million

CN¥4.23 Billion CNY

Market Cap Rank

#10833 Global

#2937 in China

Share Price

CN¥16.90

Change (1 day)

-3.59%

52-Week Range

CN¥14.65 - CN¥41.34

All Time High

CN¥85.44